Sleep Aids (Pharmacies) - Southeast Asia

Revenue in the Sleep Aids market is projected to reach US$119.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.24%, resulting in a market volume of US$161.50m by 2029.
In global comparison, most revenue will be generated United States (US$1.47bn in 2024).
In relation to total population figures, per person revenues of US$0.17 are generated in 2024.

Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. This market exclusively covers product sales through pharmacies.

Additional information:
The Sleep Aids market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Single Active Ingredient Formulations
Combination Active Ingredient Formulations
Herbal Remedies
Melatonin Products

Prescription Sleep Medications
Products for Chronic Insomnia which are not designed to address only occasional sleep challenges

The Sleep Aids (Pharmacies) market in Southeast Asia is experiencing significant growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in Southeast Asia are increasingly seeking sleep aids from pharmacies to address their sleep-related issues. This can be attributed to the rising awareness about the importance of sleep for overall health and well-being. With busy lifestyles and high stress levels, many individuals in the region are facing sleep disorders such as insomnia and sleep apnea. As a result, there is a growing demand for over-the-counter sleep aids that can help improve sleep quality and promote relaxation.

Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in Southeast Asia is the growing popularity of natural and herbal sleep aids. Customers are becoming more conscious about the potential side effects of pharmaceutical sleep aids and are opting for natural alternatives. This trend is driven by the increasing availability of natural sleep aids in pharmacies, which are often marketed as safe and effective solutions for sleep problems. Additionally, there is a growing interest in sleep aids that incorporate traditional remedies from Southeast Asian cultures, such as herbal teas and aromatherapy products.

Local special circumstances: The Sleep Aids (Pharmacies) market in Southeast Asia is also influenced by local special circumstances. For instance, in countries like Thailand and Indonesia, traditional medicine plays a significant role in healthcare practices. This has led to the development of sleep aids that are based on traditional remedies and are widely accepted by the local population. Furthermore, the high prevalence of sleep disorders in the region has prompted governments and healthcare organizations to raise awareness about sleep health and promote the use of sleep aids.

Underlying macroeconomic factors: The growth of the Sleep Aids (Pharmacies) market in Southeast Asia is supported by several underlying macroeconomic factors. Firstly, the region has been experiencing rapid urbanization and economic development, leading to increased disposable incomes and improved access to healthcare services. This has resulted in a larger consumer base for sleep aids, as more individuals can afford to purchase these products. Additionally, the aging population in Southeast Asia is driving the demand for sleep aids, as older adults are more prone to sleep disorders and require assistance in maintaining good sleep quality. In conclusion, the Sleep Aids (Pharmacies) market in Southeast Asia is witnessing growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing awareness about sleep health, the popularity of natural and herbal sleep aids, and the influence of traditional medicine are driving the demand for sleep aids in the region. Moreover, the region's rapid urbanization, economic development, and aging population are contributing to the growth of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.